250 employees
Roche Glycart is a biotechnology company, engages in the research, development, and commercialization of antibody-based products.
2000
$14M
from 5 investors over 5 rounds
Glycart Biotechnology AG raised $14M on November 26, 2003
Investors: Quest Marketing LTD, BioMedPartners, DVC Deutsche Venture Capital, Forbion and Gilde Healthcare